BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29066704)

  • 1. [Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].
    Gonda K; Tachiya Y; Hatakeyama Y; Shibata M; Kono K; Rokkaku Y
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):944-946. PubMed ID: 29066704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.
    Naiken SP; Toso C; Rubbia-Brandt L; Thomopoulos T; Roth A; Mentha G; Morel P; Gervaz P
    BMC Surg; 2014 Jan; 14():4. PubMed ID: 24438090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Pathological Complete Response of Advanced Rectal Cancer with Direct Invasion of the Prostate and Extra-Regional Lymph Node Metastasis after Chemotherapy].
    Matsuzawa F; Homma S; Miyaoka Y; Yokoyama R; Nakano S
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1525-1527. PubMed ID: 38303329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
    Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
    Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
    Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case.
    Arata R; Itamoto T; Ikeda S; Nakahara H; Oshita A; Shinozaki K; Nishisaka T
    Surg Case Rep; 2016 Dec; 2(1):106. PubMed ID: 27686666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complete clinical and pathological response to mFOLFOX6 neoadjuvant chemotherapy in a case of advanced rectal cancer].
    Mori K; Kikunaga H; Morisue A; Fujita K; Ishikawa K; Sakuragawa T; Kumai K; Miura H; Mikami S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):679-82. PubMed ID: 22504702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
    Toritani K; Watanabe J; Suwa Y; Nakagawa K; Suwa H; Ishibe A; Ota M; Kunisaki C; Yamanaka T; Endo I
    Int J Colorectal Dis; 2020 Dec; 35(12):2197-2204. PubMed ID: 32725346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
    Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
    Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.
    Perez RO; Habr-Gama A; Nishida Arazawa ST; Rawet V; Coelho Siqueira SA; Kiss DR; Gama-Rodrigues JJ
    Int J Colorectal Dis; 2005 Sep; 20(5):434-9. PubMed ID: 15759124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Advanced Rectal Cancer Resected Successfully after Induction Chemotherapy with Modified FOLFOX6 plus Panitumumab].
    Yukawa Y; Uchima Y; Kawamura M; Takeda O; Hanno H; Takayanagi S; Hirooka T; Dozaiku T; Hirooka T; Aomatsu N; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Takeuchi K
    Gan To Kagaku Ryoho; 2016 May; 43(5):641-4. PubMed ID: 27210100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two cases of advanced rectal cancer resected successfully after neoadjuvant chemotherapy with FOLFOX regimen].
    Shimizu H; Taniguchi F; Sonoda H; Itokawa Y; Ikeda J; Yamashita T; Koide K; Ueshima Y; Takashina K; Lee CJ; Shioaki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2073-5. PubMed ID: 20037327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced rectal carcinoma with multiple lung metastases responding to irinotecan combined with 5-fluorouracil and l-leucovorin (IFL) as neoadjuvant chemotherapy (NAC)].
    Fukada T; Yasuno K; Koyama T; Tanaka H; Seike K; Kametaka H; Hayashi T; Hashimoto R; Kawano H; Hasegawa A
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1665-8. PubMed ID: 17108739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer.
    Ishii Y; Hasegawa H; Endo T; Okabayashi K; Ochiai H; Moritani K; Watanabe M; Kitagawa Y
    Eur J Surg Oncol; 2010 Nov; 36(11):1061-5. PubMed ID: 20538422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of marked response to preoperative chemoradiotherapy for rectal cancer with para-aortic lymph node metastasis.
    Horiuchi A; Matsuda K; Akahane T; Shimada R; Shibuya H; Hayama T; Yamada H; Ishihara S; Nozawa K; Watanabe T
    Int Surg; 2011; 96(2):139-43. PubMed ID: 22026305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two Cases of Resectable Liver Metastasis from Colorectal Cancer with Pathological Complete Response after Neoadjuvant Chemotherapy].
    Sato H; Ii T; Rikiyama N; Noguchi A; Aoki Y; Sato J; Kikuchi D; Yamanami H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1954-1956. PubMed ID: 33468764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of rectal cancer which showed complete response to chemotherapy for para-aortic lymph node metastases remaining after surgery, for which resection of Virchow's lymph node recurrence led to long-term survival].
    Imamura H; Iino S; Sakamoto A; Kuwahata T; Yonemori K; Onishi S; Higashi H; Sakita H; Tanabe G; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1233-6. PubMed ID: 24047787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.